Literature DB >> 11936503

Recombinant feline herpesvirus type 1 expressing Toxoplasma gondi ROP2 antigen inducible protective immunity in cats.

Masayuki Mishima1, Xuenan Xuan, Naoaki Yokoyama, Ikuo Igarashi, Kozo Fujisaki, Hideyuki Nagasawa, Takeshi Mikami.   

Abstract

In order to investigate whether a recombinant viral vaccine composed of a feline herpesvirus type 1 (FHVI) vector and an immunogenic antigen of Toxoplasma gondii can induce a protective immunity in cats, a recombinant FHV1 expressing ROP2 antigen of T. gondii was prepared. We introduced a DNA fragment encoding 1-538 amino acid residues of ROP2 precursor into FHV1 genome under the control of a cytomegalovirus promoter. The recombinant FHV1 (FHV/ROP2) successfully expressed a 59 kDa antigen that was recognized by anti-ROP2 antibodies. Vaccination of cats with FHV/ROP2 induced serum IgG recognizing the native antigen. Moreover the antibodies inhibited the in vitro invasion of tachyzoites. The vaccination also accelerated the IgG response after T. gondii infection and reduced brain parasite load in cats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11936503     DOI: 10.1007/s004360100429

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  7 in total

1.  Protective efficacy of a Toxoplasma gondii rhoptry protein 13 plasmid DNA vaccine in mice.

Authors:  Pei-Yuan Wang; Zi-Guo Yuan; Eskild Petersen; Jie Li; Xiu-Xiang Zhang; Xiu-Zhen Li; Hao-Xin Li; Zhi-Cheng Lv; Tian Cheng; Di Ren; Gui-Lian Yang; Rui-Qing Lin; Xing-Quan Zhu
Journal:  Clin Vaccine Immunol       Date:  2012-09-26

Review 2.  Toxoplasma rhoptries: unique secretory organelles and source of promising vaccine proteins for immunoprevention of toxoplasmosis.

Authors:  Henryka Dlugonska
Journal:  J Biomed Biotechnol       Date:  2008

3.  An experimental Toxoplasma gondii dose response challenge model to study therapeutic or vaccine efficacy in cats.

Authors:  Jan B W J Cornelissen; Joke W B van der Giessen; Katsuhisa Takumi; Peter F M Teunis; Henk J Wisselink
Journal:  PLoS One       Date:  2014-09-03       Impact factor: 3.240

4.  DNA prime and peptide boost immunization protocol encoding the Toxoplasma gondii GRA4 induces strong protective immunity in BALB/c mice.

Authors:  Min Meng; Aihua Zhou; Gang Lu; Lin Wang; Guanghui Zhao; Yali Han; Huaiyu Zhou; Hua Cong; Qunli Zhao; Xing-Quan Zhu; Shenyi He
Journal:  BMC Infect Dis       Date:  2013-10-23       Impact factor: 3.090

Review 5.  Use of Veterinary Vaccines for Livestock as a Strategy to Control Foodborne Parasitic Diseases.

Authors:  Valeria A Sander; Edwin F Sánchez López; Luisa Mendoza Morales; Victor A Ramos Duarte; Mariana G Corigliano; Marina Clemente
Journal:  Front Cell Infect Microbiol       Date:  2020-06-26       Impact factor: 5.293

Review 6.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

Review 7.  A one health approach to vaccines against Toxoplasma gondii.

Authors:  Elisabeth A Innes; Clare Hamilton; Joao L Garcia; Andreas Chryssafidis; David Smith
Journal:  Food Waterborne Parasitol       Date:  2019-04-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.